Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 6
202
Views
0
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

The impact of ibuprofen on valproic acid plasma concentration in pediatric patients

, , , , , , , & show all
Pages 535-540 | Received 06 Jun 2022, Accepted 22 Aug 2022, Published online: 29 Aug 2022

References

  • Abbott FS, Kassam J, Orr JM, Farrell K. 1986. The effect of aspirin on valproic acid metabolisk. Clin Pharmacol Ther. 40(1):94–100.
  • Amitava D, April V. 1996. Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions. Ther Drug Monit. 18(3):284–287.
  • Battino D, Estienne M, Avanzini G. 1995. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet. 29(4):257–386.
  • Bennett S, Shad MU. 2021. Valproic acid autoinduction: a case-based review. Int J Bipolar Disord. 9(1):27.
  • Bergemann N, Kress KR, Abu-Tair F, Frick A, Kopitz J. 2006. Valproate lowers plasma concentration of olanzapine. J Clin Psychopharmacol. 26(4):432–434.
  • Bock KW. 2010. Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol. 80(6):771–777.
  • Bushra R, Aslam N. 2010. An overview of clinical pharmacology of Ibuprofen. Oman Med J. 25(3):155–1661.
  • Cerveny L, Svecova L, Anzenbacherova E, Vrzal R, Staud F, Dvorak Z, Ulrichova J, Anzenbacher P, Pavek P. 2007. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos. 35(7):1032–1041.
  • Chiappini E, Venturini E, Remaschi G, Principi N, Longhi R, Tovo PA, Becherucci P, Bonsignori F, Esposito S, Festini F, et al. 2017. 2016 update of the Italian pediatric society guidelines for management of fever in children. J Pediatr. 180:177–183. e181.
  • Citrome L, Josiassen R, Bark N, Salazar DE, Mallikaarjun S. 2005. Pharmacokinetics of aripiprazole and concomitant lithium and valproate. J Clin Pharmacol. 45(1):89–93.
  • de Jong FA, van der Bol JM, Mathijssen RH, Loos WJ, Mathot RA, Kitzen JJ, van den Bent MJ, Verweij J. 2007. Irinotecan chemotherapy during valproic acid treatment: pharmacokinetic interaction and hepatotoxicity. Cancer Biol Ther. 6(9):1368–1374.
  • Diaz FJ, Eap CB, Ansermot N, Crettol S, Spina E, de Leon J. 2014. Can valproic acid be an inducer of clozapine metabolism? Pharmacopsychiatry. 47(3):89–96.
  • Fernando L, Josep M-B, Jose dL. 2016. Ibuprofen may increase pharmacological action of valproate by displacing it from plasma proteins: a case report. Am J Psychiatry. 173(9):941–942.
  • Ghodke-Puranik Y, Thorn CF, Lamba JK, Leeder JS, Song W, Birnbaum AK, Altman RB, Klein TE. 2013. Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 23(4):236–241.
  • Huang CR, Lin CH, Hsiao SC, Chen NC, Tsai WC, Chen SD, Lu YT, Chuang YC. 2017. Drug interaction between valproic acid and carbapenems in patients with epileptic seizures. Kaohsiung J Med Sci. 33(3):130–136.
  • Jackson J, McCollum B, Ognibene J, Diaz FJ, Leon J. 2015. Three patients needing high doses of valproic acid to get therapeutic concentrations. Case Rep Psychiatry. 2015:1–12.
  • Kanabar DJ. 2017. A clinical and safety review of paracetamol and ibuprofen in children. Inflammopharmacology. 25(1):1–9.
  • Lana F, Martí-Bonany J, Fuster J, Leon J. 2016. Reduction in serum concentration of valproic acid secondary to the intake of ibuprofen as an example of valproic acid auto-induction metabolism. Actas Esp Psiquiatr. 44(4):136–144.
  • Mankin KP, Scanlon M. 1998. Side effect of ibuprofen and valproic acid. Orthopedics. 21(3):264–270.
  • McLaughlin DB, Andrews JA, Hooper WD, Cannell GR, Eadie MJ, Dickinson RG. 2000. Apparent autoinduction of valproate b-oxidation in humans. Br J Clin Pharmacol. 49(5):409–415.
  • Neels H, Sierens A, Naelaerts K, Scharpe S, Hatfield G, Lambert W. 2004. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med. 42(11):1228–1255.
  • Orr JM, Abbott FS, Farrell K, Ferguson S, Sheppard I, Godolphin W. 1982. Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects. Clin Pharmacol Ther. 31(5):642–649.
  • Patsalos P, Berry D, Bourgeois B, Cloyd J, Glauser T, Johannessen S, Leppik I, Tomson T, Perucca E. 2008. Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring. ILAE Commission on Therapeutic Strategies. Epilepsia. 49(7):1239–1276.
  • Patsalos PN, Perucca E. 2003. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol. 2(8):473–481.
  • Patsalos PN, Spencer EP, Berry DJ. 2018. Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update. Ther Drug Monit. 40(5):526–548.
  • Paul IM, Walson PD. 2021. Acetaminophen and ibuprofen in the treatment of pediatric fever: a narrative review. Curr Med Res Opin. 37(8):1363–1375.
  • Perucca E. 2002. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 16(10):695–714.
  • Pierce CA, Voss B. 2010. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review. Ann Pharmacother. 44(3):489–506.
  • Sandson NB, Marcucci C, Bourke DL, Smith-Lamacchia R. 2006. An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions. Am J Psychiatry. 163(11):1891–1896.
  • Tan E, Braithwaite I, McKinlay CJD, Dalziel SR. 2020. Comparison of acetaminophen (paracetamol) with ibuprofen for treatment of fever or pain in children younger than 2 years: a systematic review and meta-analysis. JAMA Netw Open. 3(10):e2022398.
  • Torbjörn T, Dina B, Emilio P. 2016. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol. 15(2):210–218.
  • Wheless J, Clarke D, Arzimanoglou A, Carpenter D. 2007. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord. 9(4):353–412.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.